نتائج البحث - "Lyashchenko N."

1

دورية أكاديمية

The Role of Cryptocurrencies in Financial and Economic Systems

المؤلفون: Burkovska A., Lyashchenko N.

المصدر: Modern Economics, Vol 18, Pp 20-25 (2019)

مصطلحات موضوعية: cryptocurrency, blockchain, fiat money, virtual currency, bitcoin, cashless payments, electronic money, Business, HF5001-6182, Finance, HG1-9999

وصف الملف: electronic resource

العلاقة: https://modecon.mnau.edu.ua/issue/18-2019/burkovska.pdfTest; https://doaj.org/toc/2521-6392Test

الوصول الحر: https://doaj.org/article/9d6e5bae5c8645ccbf7ed15eab8adbe3Test

View record in DOAJ

2

دورية أكاديمية

Mathematical modeling of ischemic stroke ; Математическое моделирование ишемического инсульта

المؤلفون: V. Ershov I., A. Chirkov N., A. Gonchar-Zaykin P., S. Lyashchenko N., T. Lozinskaya Yu., N. Gumalatova V., G. Kuznetsov E., L. Tenchurina R., В. Ершов И., А. Чирков Н., А. Гончар-Зайкин П., С. Лященко Н., Т. Лозинская Ю., Н. Гумалатова В., Г. Кузнецов Э., Л. Тенчурина Р.

المصدر: Neurology, Neuropsychiatry, Psychosomatics; Vol 11, No 4 (2019); 38-43 ; Неврология, нейропсихиатрия, психосоматика; Vol 11, No 4 (2019); 38-43 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2019-4

مصطلحات موضوعية: ischemic stroke, pathogenetic subtype, osmolarity, ишемический инсульт, патогенетический подтип, осмолярность

وصف الملف: application/pdf

العلاقة: https://nnp.ima-press.net/nnp/article/view/1207/961Test; Гафаров ВВ, Громова ЕА, Панов ДО и др. Социальная поддержка и риск инсульта: эпидемиологическое исследование населения в возрасте 25-64 лет в России/Сибири (программа ВОЗ MONICA-psychosocial). Неврология, нейропсихиатрия, психосоматика. 2019;11(1):12-20. doi:10.14412/2074-2711-2019-1-12-20; Гусев ЕИ, Скворцова ВИ, Стаховская ЛВ. Проблема инсульта в Российской Федерации: время активных совместных действий. Журнал неврологии и психиатрии им. С.С. Корсакова. 2007;107(6):4-10.; Гусев ЕИ, Мартынов МЮ, Камчатнов ПР и др. Церебральный инсульт. Consilium Medicum. 2014;16(12):13-7.; Клочихина ОА, Стаховская ЛВ. Анализ эпидемиологических показателей инсульта по данным территориально-популяционных регистров 2009-2012 гг. Журнал неврологии и психиатрии им. С.С. Корсакова. 2014;114(6): 63-9.; Стаховская ЛВ, Клочихина ОА, Богатырева МД и др. Эпидемиология инсульта в России по результатам территориально-популяционного регистра (2009-2010). Журнал неврологии и психиатрии им. C.C. Корсакова. 2013;113(5-1):4-10.; Favate AS. Epidemiology of ischemic stroke. Neurol Clin. 2016 Nov;34(4):967-980. doi:10.1016/j.ncl.2016.06.013.; Кулеш АА, Кайлева НА, Горст НХ и др. Связь между интегральной оценкой магнитно-резонансных маркеров церебральной болезни мелких сосудов, клиническим и функциональным статусом в остром периоде ишемического инсульта. Неврология, нейропсихиатрия, психосоматика. 2018;10(1):24-31. doi: 0.14412/2074-2711-2018-1-24-31; Филимонова ПА, Волкова ЛИ, Алашеев АМ и др. Внутрибольничный инсульт у пациентов после кардиохирургических операций и инвазивных вмешательств на сердце. Неврология, нейропсихиатрия, психосоматика. 2017;9(4):38-45. Doi: 0.14412/2074-2711-2017-4-38-45; Widimsky P. What is new in ischemic stroke? Dialogues in Cardiovascular Medicine. 2017; 22(3):25-26.; Савин ИА, Попугаев КА, Ошоров АВ и др. Несахарный диабет в остром периоде субарахноидального кровоизлияния. Анестезиология и реаниматология. 2007;(2): 57-62. [Savin IA, Popugaev KA, Oshorov AV, et al. Diabetes insipidus in the acute period of subarachnoid hemorrhage. Anesteziologiya i reanimatologiya. 2007;(2):57-62. (InRuss.)].; Щекочихин ДЮ, Козловская НЛ, Копылов ФЮ и др. Гипонатриемия: клинический подход. Терапевтический архив. 2017;89(8): 134-40.; Balasubramanian A, Flareau D, Sourbeer J. Syndrome of Inappropriate Antidiuretic Hormone Secretion. Hospital Physician. 2007 Apr;39:33-6.; Kembuan MAHN, Sekeon SAS. Electrolyte disturbances among acute stroke patients in Manado, Indonesia. GJMEDPH. 2014;3(1).; Савин ИА, Горячев АС. Водно-электролитные нарушения в нейрореанимации. Москва; 2015.; Peri A. Parenti G, Pirozzi N, et al. Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). J Endocrinol Invest. 2010 Oct;33(9):671-82. doi:10.1007/BF03346668. Epub 2010 Oct 8.; Rost N, Biffi A, Cloonan L, et al. Brain Natriuretic Peptide Predicts Functional Outcome in Ischemic Stroke. Stroke. 2012 Feb; 43(2):441-5. doi:10.1161/STROKEAHA.111.629212. Epub 2011 Nov 23.; Sherlock M, Thompson CJ. The syndrome of inappropriate antidiuretic hormone: current and future management options. Eur J Endocrinol. 2010 Jun;162 Suppl 1:S13-8. doi:10.1530/EJE-09-1057. Epub 2010 Feb 17.; Sviri GE, Shik V, Raz B, Soustiel JF. Role of brain natriuretic peptide in cerebral vasospasm. Acta Neurochir (Wien). 2003 Oct; 145(10):851-60; discussion 860.; Vinay PA, Daneault S, Seck M, et al. SIADH syndrome related to the dying process. Medecine Palliative. 2011;10(3):137-143.; Янишевский СН. Современные стратегии повышения эффективности и безопасности профилактики и лечения эмболического инсульта при неклапанной фибрилляции предсердий, возможности нейтрализующей терапии. Неврология, нейропсихиатрия, психосоматика. 2018;10(3):116-20. doi:10.14412/2074-2711-2018-3-116-120; Чирков АН, Ершов ВИ. Прогностическое значение водно-электролитных нарушений в острейший период тяжелого ишемического инсульта. Анестезиология и реаниматология. 2016;61(6):404-7.; Kim YD, Hong HJ, Cha MJ, et al. Determinants of infarction patterns in cardioembolic stroke. Eur Neurol. 2011;66(3):145-50. doi:10.1159/000330563. Epub 2011 Aug 26.; Kolominsky-Rabas PL, Weber M, Gefeller O, et al. Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes, a population-based study. Stroke. 2001 Dec 1;32(12):2735-40.; Mehndiratta P, Worrall BB, Chapman SS. Etiologic stroke subtypes: updated definition and efficient workup strategies. Curr Treat Options Cardiovasc Med. 2015 Jan;17(1):357. doi:10.1007/s11936-014-0357-7.; Memon RA, Dahri AH, Memon S. Frequency and type of stroke in hypertensive patients. Medical Forum Monthly. 2011;22(10):31-34.; Bhalla A, Sankaralingam S, Dundas R, et al. Influence of Raised Plasma Osmolality on Clinical Outcome After Acute Stroke. Stroke. 2000 Sep;31(9):2043-8.; Montaner J, Perea-Gainza M, Delgado P, et al. Etiologic Diagnosis of Ischemic Stroke Subtypes With Plasma Biomarkers. Stroke. 2008 Aug;39(8):2280-7. doi:10.1161/STROKEAHA.107.505354. Epub 2008 Jun 5.; Wessler BS, Kent DM. Controversies in cardioembolic stroke. Curr Treat Options Cardiovasc Med. 2015 Jan;17(1):358. doi:10.1007/s11936-014-0358-6.; Ершов ВИ, Чирков АН. Алгоритмы коррекции водно-электролитных нарушений у пациентов с тяжелым ишемическим инсультом. Журнал неврологии и психиатрии им. C.C. Корсакова. 2017;117(3/2):31-4.; Ершов ВИ, Чирков АН. Гиперволемическая гипернатриемия в дебюте тяжелого ишемического инсульта как предиктор неблагоприятного исхода. Журнал неврологии и психиатрии им. C.C. Корсакова. 2016; 116(6):10-3.; https://nnp.ima-press.net/nnp/article/view/1207Test

الإتاحة: https://doi.org/10.14412/2074-2711-2019-4-38-43Test
https://doi.org/10.14412/2074-2711-2019-4Test
https://doi.org/10.14412/2074-2711-2019-1-12-20Test
https://doi.org/10.1016/j.ncl.2016.06.013Test
https://doi.org/10.1007/BF03346668Test
https://doi.org/10.1161/STROKEAHA.111.629212Test
https://doi.org/10.1530/EJE-09-1057Test
https://doi.org/10.14412/2074-2711-2018-3-116-120Test
https://doi.org/10.1159/000330563Test
https://doi.org/10.1007/s11936-014-0357-7Test

View record in BASE

3

دورية أكاديمية

Nutritional status in patients with cystic fi brosis before and after lung transplantation ; Статус питания больных муковисцидозом до и после трансплантации легких

المؤلفون: M. Khubutiya Sh., M. Il'inskiy E., A. Ryk A., Yu. Lyashchenko N., М. Хубутия Ш., М. Ильинский Е., А. Рык А., Ю. Лященко Н.

المصدر: Transplantologiya. The Russian Journal of Transplantation; Том 9, № 2 (2017); 125-136 ; Трансплантология; Том 9, № 2 (2017); 125-136 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2017-9-2

مصطلحات موضوعية: cystic fibrosis, nutritional status, lung transplantation, муковисцидоз, статус питания, трансплантация легких

وصف الملف: application/pdf

العلاقة: https://www.jtransplantologiya.ru/jour/article/view/167/206Test; https://www.jtransplantologiya.ru/jour/article/view/167/241Test; Cohen-Cymberknoh M., Shoseyov D., Kerem E. Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life. Am. J. Respir. Crit. Care Med. 2011;183(11):1463–1471. PMID:21330455 DOI:10.1164/rccm.201009-1478CI; Li L., Somerset S. Digestive system dysfunction in cystic fibrosis: challenges for nutrition therapy. Dig. Liver Dis. 2014;46(10):865–874. PMID:25053610 DOI:10.1016/j.dld.2014.06.011; Culhane S., George C., Pearo B., Spoede E. Malnutrition in cystic fibrosis: a review. Nutr. Clin. Pract. 2013;28(6):676–683. PMID:24170579 DOI:10.1177/0884533613507086; Corey M., McLaughlin F.J., Williams M., Levison H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J. Clin. Epidemiol. 1988;41(6):583–591. PMID:3260274; Stallings V.A., Stark L.J., Robinson K.A. Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. J. Am. Diet. Assoc. 2008;108(5):832–839. PMID:18442507 DOI:10.1016/j.jada.2008.02.020; Петрова Н.В., Гинтер Е.К. Молекулярно-генетические аспекты муковисцидоза. В кн.: под ред. Капранова Н.И., Каширской Н.Ю. Муковисцидоз. М.: МЕДПРАКТИКА-М, 2014: 37–80.; Andersen D.H., Dorothy H. Cystic fibrosis of the pancreas and its relation to celiac disease: a clinical and pathological study. Am. J. Dis. Child. 1938;56(2):344–399. DOI:10.1001/archpedi.1938.01980140114013; Stephenson A.L., Mannik L.A., Walsh S. et al. Longitudinal trends in nutritional status and the relation between lung function and BMI in cystic fibrosis: a population-based cohort study. Am. J. Clin. Nutr. 2013;97(4):872–877.; Амелина Е.Л., Гембицкая Т.Е., Черменская А.Г. Особенности муковисцидоза взрослых. В кн.: под ред. Капранова Н.И., Каширской Н.Ю. Муковисцидоз. М.: МЕДПРАКТИКА-М, 2014: 548–575.; Robinson P.J., Smith A.L., Sly P.D. Duodenal pH in cystic fibrosis and its relationship to fat malabsorption. Dig. Dis. Sci. 1990;35(10):1299–1304. PM-ID:2120019; Perano S., Rayner C.K., Couper J. et al. Cystic fibrosis related diabetes – a new perspective on the optimal management of postprandial glycemia. J. Diabetes Complicat. 2014;28(6):904–911. PMID:25060530 DOI:10.1016/j.jdiacomp.2014.06.012; Debray D., Kelly D., Houwen R. et al. Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease. J. Cyst. Fibros. 2011;10(Suppl 2):S29–S36. PMID:21658639 DOI:10.1016/S1569-1993(11)60006-4; Каширская Н.Ю. Поражение поджелудочной железы, изменения со стороны гепатобилиарной системы у больных муковисцидозом. В кн.: под ред. Капранова Н.И., Каширской Н.Ю. Муковисцидоз. М.: МЕДПРАКТИКА-М, 2014: 295–345.; Moran A., Dunitz J., Nathan B. et al. Cystic fibrosisrelated diabetes: current trends in prevalence, incidence, and mortality. Diabetes Care. 2009;32(9):1626– 1631. PMID:19542209 DOI:10.2337/dc09-0586; Waugh N., Royle P., Craigie I. et al. Screening for cystic fibrosis-related diabetes: a systematic review. Health Technol. Assess. 2012;16(24):iii–iv,1–179. PMID:22572153 DOI:10.3310/hta16240; Moran A., Pillay K., Becker D.J. ISPAD Clinical Practice Consensus Guidelines 2014. Management of cystic fibrosis related diabetes in children and adolescents. Pediatr. Diabetes. 2014;15(Suppl 20):65–76. PMID:25182308 DOI:10.1111/pedi.12178; Moran A., Brunzell C., Cohen R.C. et al. Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care. 2010;33(12):2697–2708. PMID:21115772 PMCID:PMC2992215 DOI:10.2337/dc10-1768; Colombo C., Battezzati P.M., Crosignani A. et al. Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome. Hepatology. 2002;36(6):1374– 1382. PMID:12447862 DOI:10.1053/jhep.2002.37136; Lindblad A., Glaumann H., Strandvik B. Natural history of liver disease in cystic fibrosis. Hepatology. 1999;30(5):1151– 1158. PMID:10534335 DOI:10.1002/hep.510300527; Van Biervliet S., Van Biervliet J.P., Robberecht E., Christophe A. Fatty acid composition of serum phospholipids in cystic fibrosis (CF) patients with or without CF related liver disease. Clin. Chem. Lab. Med. 2010;48(12):1751– 1755. PMID:20961201 DOI:10.1515/CCLM.2010.336; Conway S.P., Morton A.M., Oldroyd B. et al. Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors. Thorax. 2000;55(9):798– 804. PMID:10950902; Gronowitz E., Lorentzon M., Ohlsson C. et al. Docosahexaenoic acid is associated with endosteal circumference in long bones in young males with cystic fibrosis. Br. J. Nutr. 2008;99(1):160– 167. PMID:17697399 DOI:10.1017/S000711450780105X; Yen E.H., Quinton H., Borowitz D. Better nutritional status in early childhood is associated with improved clinical outcomes and survival in patients with cystic fibrosis. J. Pediatr. 2013;162(3):530– 535. PMID:23062247 DOI:10.1016/j.jpeds.2012.08.040; Kerem E., Viviani L., Zolin A. et al. Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS Patient Registry. Eur. Respir J. 2014;43(1):125–133. PMID:23598952 DOI:10.1183/09031936.00166412; Sinaasappel M., Stern M., Littlewood J. et al. Nutrition in patients with cystic fibrosis: a European Consensus. J. Cyst. Fibros. 2002;1(2):51–75. PM-ID:15463811; Smyth A.R., Bell S.C., Bojcin S. et al. European cystic fibrosis Society standards of care: best practice guidelines. J. Cyst. Fibros. 2014;13(Suppl 1):S23– S42. PMID:24856775 DOI:10.1016/j.jcf.2014.03.010; Turck D., Braegger C.P., Colombo C. et al. ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis. Clin. Nutr. 2016;35(3):557–577. PMID:27068495 DOI:10.1016/j.clnu.2016.03.004; Thomson M.A., Bucolo S., Quirk P., Shepherd R.W. Measured versus predicted resting energy expenditure in infants: a need for reappraisal. J. Pediatr. 1995;126(1):21–27. PMID:7815217; Thomson M.A., Wilmott R.W., Wainwright C. et al. Resting energy expenditure, pulmonary inflammation, and genotype in the early course of cystic fibrosis. J. Pediatr. 1996;129(3):367–373. PMID:8804325; Wood L.G., Gibson P.G., Garg M.L. Circulating markers to assess nutritional therapy in cystic fibrosis. Clin. Chim. Acta. 2005;353(1–2):13–29. PMID:15698587 DOI:10.1016/j.cccn.2004.11.002; Cystic Fibrosis Trust. Nutritional management of cystic fibrosis. London, UK, 2002.; Powers S.W., Mitchell M.J., Patton S.R. et al. Mealtime behaviors in families of infants and toddlers with cystic fibrosis. J. Cyst. Fibros. 2005;4(3):175– 182. PMID:15982934 DOI:10.1016/j.jcf.2005.05.015; Gaskin K. J. Nutritional care in children with cystic fibrosis: are our patients becoming better? Eur. J. Clin. Nutr. 2013;67(5):558–564. PMID:23462946 DOI:10.1038/ejcn.2013.20; Olveira G., Olveira C., Acosta E. et al. Fatty acid supplements improve respiratory, inflammatory and nutritional parameters in adults with cystic fibrosis. Arch. Bronconeumol. 2010;46(2):70– 77. PMID:20045240 DOI:10.1016/j.arbres.2009.11.001; Keen C., Olin A.C., Eriksson S. et al. Supplementation with fatty acids influences the airway nitric oxide and inflammatory markers in patients with cystic fibrosis. J. Pediatr. Gastroenterol. Nutr. 2010;50(5):537–544. PMID:20639712 DOI:10.1097/MPG.0b013e3181b47967; Oliver C., Watson H. Omega-3 fatty acids for cystic fibrosis. Cochrane Database Syst. Rev. 2013;11:CD002201. PMID:24282091 DOI:10.1002/14651858.CD002201.pub4; Sermet-Gaudelus I., Bianchi M.L., Garabédian M. et al. European cystic fibrosis bone mineralisation guidelines. J. Cyst. Fibros. 2011;10(Suppl 2):S16–S23. PMID:21658635 DOI:10.1016/S1569-1993(11)60004-0; Cystic Fibrosis Trust. Bone mineralisation in cystic fibrosis. London, UK, 2007.; Chinuck R., Dewar J., Baldwin D.R., Hendron E. Appetite stimulants for people with cystic fibrosis. Cochrane Database Syst Rev. 2014;7:CD008190. PMID:25064192 DOI:10.1002/14651858.CD008190.pub2; Bruzzese E., Raia V., Gaudiello G. et al. Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration. Aliment. Pharmacol. Ther. 2004;20(7):813–819. PMID:15379842 DOI:10.1111/j.1365-2036.2004.02174.x; Bruzzese E., Raia V., Spagnuolo M.I. et al. Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: a pilot study. Clin. Nutr. 2007;26(3):322–328. PMID:17360077 DOI:10.1016/j.clnu.2007.01.004; Kindstedt-Arfwidson K., Strandvik B. Food intake in patients with cystic fibrosis on an ordinary diet. Scand. J. Gastroenterol. Suppl. 1988;143:160–162. PMID:3164504; Smith C., Winn A., Seddon P., Ranganathan S. A fat lot of good: balance and trends in fat intake in children with cystic fibrosis. J. Cyst. Fibros. 2012;11(2):154–157. PMID:22119390 DOI:10.1016/j.jcf.2011.10.007; Woestenenk J.W., Castelijns S.J., van der Ent C.K., Houwen R.H. Dietary intake in children and adolescents with cystic fibrosis. Clin Nutr. 2014;33(3):528– 532. PMID: 23920501 DOI:10.1016/j.clnu.2013.07.011; Cystic Fibrosis Foundation Patient Registry. Annual Data 2012. Bethesda, Maryland, 2013.; Steinkamp G., Demmelmair H., Rühl-Bagheri I. et al. Energy supplements rich in linoleic acid improve body weight and essential fatty acid status of cystic fibrosis patients. J. Pediatr. Gastroenterol. Nutr. 2000;31(4):418–423. PMID:11045840; Rettammel A.L., Marcus M.S., Farrell P.M. et al. Oral supplementation with a high-fat, high-energy product improves nutritional status and alters serum li pids in patients with cystic fibrosis. J. Am. Diet. Assoc. 1995;95(4):454–459. PMID:7699188 DOI:10.1016/S0002-8223(95)00121-2; Alison J.A., Donnelly P.M., Lennon M. et al. The effect of a comprehensive, intensive inpatient treatment program on lung function and exercise capacity in patients with cystic fibrosis. Phys. Ther. 1994;74(6):583–591. PMID:8197244; Heijerman H.G. Chronic obstructive lung disease and respiratory muscle function: the role of nutrition and exercise training in cystic fibrosis. Respir. Med. 1993;87(Suppl. B):49–51. PMID:8234970; Williams S.G., Ashworth F., McAlweenie A. et al. Percutaneous endoscopic gastrostomy feeding in patients with cystic fibrosis. Gut. 1999;44(1):87–90. PMID:9862831; Rosenfeld M., Casey S., Pepe M., Ramsey B.W. Nutritional effects of longterm gastrostomy feedings in children with cystic fibrosis. J. Am. Diet. Assoc. 1999;99(2): 191– 194. PMID:9972186 DOI:10.1016/S0002-8223(99)00046-2; Allen E.D., Mick A.B., Nicol J., McCoy K.S. Prolonged parenteral nutrition for cystic fibrosis patients. Nutr. Clin. Pract.1995;10(2):73–79. PMID:7731428 DOI:10.1177/011542659501000273; Авдеев С.Н. Трансплантация легких при муковисцидозе. В кн.: под ред. Капранова Н.И., Каширской Н.Ю. Муковисцидоз. М.: МЕДПРАКТИКА-М, 2014: 595–611.; Spahr J.E., Love R.B., Francois M. et al. Lung transplantation for cystic fibrosis: current concepts and one center's experience . J. Cyst. Fibros. 2007;6(5):334–350. PMID:17418647 DOI:10.1016/j.jcf.2006.12.010; Stehlik J., Edwards L.B., Kucheryavaya A.Y. et al. The Registry of the International Society for Heart and Lung transplantation: 29th adult lung and heart-lung transplant report – 2012. J. Heart Lung. Transplant. 2012;31(10):1073–1086. PMID:22975095DOI:10.1016/j.healun.2012.08.002; Lederer D.J., Wilt J.S., D'Ovidio F. et al. Obesity and underweight are associated with an increased risk of death after lung transplantation. Am. J. Respir. Crit. Care Med. 2009;180(9):887– 895. PMID:19608717 DOI:10.1164/rccm.200903-0425OC; Регистр больных муковисцидозом в Российской Федерации. 2011 г. Пульмонология. 2014; Прил. Режим доступа: http://mukoviscidoz.org/doc/registr/Registr_end_2011.pdfTest; Egan J.J., Woodcock A.A., Webb A.K. Management of cystic fibrosis before and after lung transplantation. J. R. Soc. Med.1997;90(Suppl 31):47–58. PMID:9204012; Elborn J.S., Jagoe T., Shale D.J. Metabolic and respiratory consequences of a glucose load in hypoxic patients with cystic fibrosis. Ulster Med. 1992;61(2):188– 192. PMID:1481313; Hirche T.O., Knoop C., Hebestreit H. et al. Practical Guidelines: Lung Transplantation in Patients with Cystic Fibrosis. Pulm. Med. 2014;2014:621342. PMID:24800072 DOI:10.1155/2014/621342; Tynan C., Hasse J.M. Current nutrition practices in adult lung transplantation. Nutr. Clin. Pract. 2004;19(6):587–596. PMID:16215158 DOI:10.1177/0115426504019006587; Kalnins D., Wilschanski M. Maintenance of nutritional status in patients with cystic fibrosis: new and emerging therapies. Drug. Des. Devel. Ther. 2012;6:151–161. PMID:22787388 DOI:10.2147/DDDT.S9258; Ho T., Gupta S., Brotherwood M. et al. Increased serum vitamin A and e levels after lung transplantation. Transplantation. 2011;92(5):601–606. PMID:21841542 DOI:10.1097/TP.0b013e31822790e3; Stephenson A., Brotherwood M., Robert R. et al. Increased vitamin A and E levels in adult cystic fibrosis patients after lung transplantation. Transplantation. 2005;79(5):613– 615. PMID:15753854; Hadjiliadis D., Madill J., Chaparro C. et al. Incidence and prevalence of diabetes mellitus in patients with cystic fibrosis undergoing lung transplantation before and after lung transplantation. Clinical Transplantation. 2005;19(6):773– 778. PMID:16313324 DOI:10.1111/j.1399-0012.2005.00420.x; Gottlieb J., Ballmann M., von Mallinckrodt C. et al. Lung transplantation in cystic fibrosis - a position paper. Pneumologie. 2009;63(8):451–460. PMID:19670104 DOI:10.1055/s-0029-1214821; Gilljam M., Chaparro C., Tullis E. et al. GI complications after lung transplantation in patients with cystic fibrosis. Chest. 2003;123(1):37–41. PMID:12527600; Atkins B.Z., Petersen R.P., Daneshmand M.A. et al. Impact of oropharyngeal dysphagia on long-term outcomes of lung transplantation. Ann. Thorac. Surg. 2010;90(5):1622–1628. PMID:20971276 DOI:10.1016/j.athoracsur.2010.06.089; Dellon E.S., Morgan D.R., Mohanty S.P. et al. High incidence of gastric bezoars in cystic fibrosis patients after lung transplantation. Transplantation. 2006;81(8):1141–1146. PMID:16641599 DOI:10.1097/01.tp.0000205813.54136.85; Mendez B.M., Davis C.S., Weber C. et al. Gastroesophageal reflux disease in lung transplant patients with cystic fibrosis. Am. J. Surg. 2012;204(5):e21– e26. PMID:22921151 DOI:10.1016/j.amjsurg.2012.07.019; Quon B.S., Mayer-Hamblett N., Aitken M.L., Goss C.H. Risk of post lung transplant renal dysfunction in adults with cystic fibrosis. Chest. 2012;142(1):185– 191. PMID:22222189 DOI:10.1378/chest.11-1926; Outbreak of Salmonella serotype Javinia infections. Orlando, Florida, June 2002. MMWR Morb Mortal Wkly Rep. 2002;51(31):683–684. PMID:12233909; Goulet V., Hebert M., Hedberg C. et al. Incidence of listeriosis and relate d mortality among groups at risk of acquiring listeriosis. Clin. Infect. Dis. 2012;54(5):652–660. PMID:22157172 DOI:10.1093/cid/cir902; Mathur S., Hornblower E., Levy R.D. Exercise training before and after lung transplantation. Phys. Sportsmed. 2009;37(3):78–87. PMID:20048531 DOI:10.3810/psm.2009.10.1732; https://www.jtransplantologiya.ru/jour/article/view/167Test

View record in BASE

4

دورية أكاديمية

EXPERIMENTAL BASIS OF THE MICROSURGICAL ESOPHAGEAL-INTESTINAL ANASTOMOSIS ; ЭКСПЕРИМЕНТАЛЬНОЕ ОБОСНОВАНИЕ МИКРОХИРУРГИЧЕСКОГО ПИЩЕВОДНО-ТОНКОКИШЕЧНОГО АНАСТОМОЗА

المؤلفون: M. Makaev I., O. Abramzon M., S. Lyashchenko N., М. Макаев И., О. Абрамзон М., С. Лященко Н.

المصدر: Creative surgery and oncology; № 3 (2014); 23-25 ; Креативная хирургия и онкология; № 3 (2014); 23-25 ; 2076-3093 ; 2307-0501 ; 10.24060/2076-3093-2014-0-3

مصطلحات موضوعية: microsurgery, esophageal-intestinal anastomosis, микрохирургия, пищеводно-тонкокишечный анастомоз

وصف الملف: application/pdf

العلاقة: https://www.surgonco.ru/jour/article/view/20/21Test; Каган И.И., Макаев М.И., Лященко С.Н., Абрамзон О.М. Морфологическое обоснование восстановления целостности пищеварительного тракта с применением микрохирургического пищеводно-тонкокишечного анастомоза // Фундаментальные исследования. – 2014. – №2. – С.73-76.; Каган И.И. Микрохирургическая техника и деминерализованная кость в восстановительной хирургии полых органов и кровеносных сосудов. – СПб.: Эскулап, 1996. – 122 с.; Макаев М.И., Лященко С.Н., Абрамзон О.М. Морфологическое обоснование микрохирургического пищеводно-тонкокишечного анастомоза // Современные проблемы науки и образования. – 2014. – № 1; URL: http://www.science-educationTest. ru/115-12119.; Поликарпов С.А., Лисицкий А.Н., Горюнов И.В., Сулейманов М.У. Выбор метода наложения пищеводно-кишечного анастомоза после гастрэктомии // Хирургия. – 2008. – №9. – С. 56-60.; Черноусов А.Ф., Черноусов Ф.А., Ручкин Д.В. Опыт применения ручных пищеводно-желудочных анастомозов при субтотальной эзофагопластике // Анналы хирургии. – 1999. – №3. – С. 26-30.; What have we learned from surgical treatment of gastric adenocarcinoma? A comparison of two periods / S. Potrc, R. Kavalar, T. Hajdinjak et al. // Wien KlinWochenschr. – 2004. – Vol. 116. - Suppl. 2. – P. 56- 59; https://www.surgonco.ru/jour/article/view/20Test

الإتاحة: https://doi.org/10.24060/2076-3093-2014-0-3-23-25Test
https://doi.org/10.24060/2076-3093-2014-0-3Test
https://www.surgonco.ru/jour/article/view/20Test

View record in BASE

5

دورية أكاديمية

RECENT ADVANCES OF HYPERMETABOLIC RESPONSE MODULATION IN SEVERE THERMAL TRAUMA ; СОВРЕМЕННЫЕ ВОЗМОЖНОСТИ СНИЖЕНИЯ ИНТЕНСИВНОСТИ ГИПЕРМЕТАБОЛИЗМА ПРИ ТЯЖЕЛОЙ ТЕРМИЧЕСКОЙ ТРАВМЕ (ОБЗОР ЛИТЕРАТУРЫ)

المؤلفون: M. Ilynsky Y., Y. Lyashchenko N., A. Ryk A., D. Bocharov E., М. Ильинский Е., Ю. Лященко Н., А. Рык А., Д. Бочаров Э.

المصدر: Russian Sklifosovsky Journal "Emergency Medical Care"; № 3 (2016); 55-64 ; Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь»; № 3 (2016); 55-64 ; 2541-8017 ; 2223-9022 ; undefined

مصطلحات موضوعية: hypermetabolic response, burn injury, nutritional support, гиперметаболический ответ, ожоговая травма, искусственное питание

وصف الملف: application/pdf

العلاقة: https://www.jnmp.ru/jour/article/view/296/361Test; Peck M.D. Epidemiology of burns throughout the world. Part I: Distribution and risk factors // Burns. – 2011. – Vol. 37, N. 7. – Р. 1087–1100.; Brusselaers N., Monstrey S., Vogelaers D., et al. Severe burn injury in Europe: a systematic review of the incidence, etiology, morbidity, and mortality // Crit. Care. – 2010. – Vol. 14, N. 5. – R188.; Wolf S. Critical Care in the Severely burned: organ support and management of complications // Total burn care / ed. D.N. Herndon. – 3rd ed. – London: Saunders Elsevier, 2007. – P. 454–476.; Смирнов С.В., Лященко Ю.Н., Спиридонова Т.Г., Рык А.А. Энтеральное и парентеральное питание пострадавших с термической травмой // Парентеральное и энтеральное питание: нац. руководство / под ред. М.Ш. Хубутия, Т.С. Поповой, А.И. Салтанова. – М.: ГЭОТАРМедиа, 2014. – С. 351–370.; Herndon D.N., Tompkins R.G. Support of the metabolic response to burn injury // Lancet. – 2004. – N. 363. – P. 1895–1902.; Герасимова Л.И. Термические ожоги // Искусственное питание в неотложной хирургии и травматологии / под ред. А.С. Ермолова, М.М. Абакумова. – М.: НИИ СП имени Н.В. Склифосовского, 2001. – С. 239–264.; Sheridan R.L. A great constitutional disturbance // N. Engl. J. Med. – 2001. – Vol. 345, N. 17. – P. 1271–1272.; Yu Y.M., Tompkins R.G., Ryan C.M., Young V.R. The metabolic basis of the increase in energy expenditure in severely burned patients // JPEN J. Parenter. Enteral. Nutr. – 1999. – Vol. 23, N. 3. – P. 160–168.; Demling R., Seigne P. Metabolic management of patients with severe burns // World J. Surg. – 2000. – Vol. 24, N. 6. – P. 673–680.; Newsome T., Mason A., Pruitt B. Weight loss following thermal injury // Ann. Surg. 1973. – Vol. 178, N. 2. – P. 215–217.; Wilmore D.W. Nutrition and metabolism following thermal injury // Clin. Plast. Surg. – 1974. – Vol. 1, N. 4. – P. 603–619.; Jeschke M.G., Mlcak R.P., Finnerty C.C., et al. Burn size determines the inflammatory and hypermetabolic response // Crit. Care. – 2007. – Vol. 11, N. 4. – R90.; Norbury W.B., Herndon D.N. Modulation of the hypermetabolic response after burn injury // Total burn care / ed. D.N. Herndon D.N. – 3rd ed. – New York: Saunders Elsevier, 2007. – P. 420–433.; Zawacki B.E., Spitzer K.W., Mason A.D. Jr., et al. Does increased evaporative water loss cause hypermetabolism in burned patients? // Ann. Surg. – 1970. – Vol. 171, N. 2. – P. 236–240.; Wilmore D.W., Mason A.D. Jr., Johnson D.W., Pruitt B.A. Effect of ambient temperature on heat production and heat loss in burn patients // J. Appl. Physiol. – 1975. – Vol. 38, N. 4. – P. 593–597.; Williams F.N., Jeschke M.G., Chinkes D.L., et al. Modulation of the hypermetabolic response to trauma: temperature, nutrition, and drugs // J. Am. Coll. Surg. – 2009. – Vol. 208, N. 4. – P. 489–502.; Munster A.M., Smith-Meek M., Sharkey P. The effect of early surgical intervention on mortality and cost-effectiveness in burn care, 1978–1991 // Burns. – 1994. – Vol. 20, N. 1. – P. 61–64.; Ramzy P.I., Barret J.P., Herndon D.N. Thermal injury // Crit. Care Clin. – 1999. – Vol. 15, N. 2. – P. 333–352, ix.; Hart D.W., Wolf S.E., Chinkes D.L., et al. Determinants of skeletal muscle catabolism after severe burn // Ann. Surg. – 2000. – Vol. 232, N. 4. – P. 455–465.; Cucuzzo N.A., Ferrando A., Herndon D.N. The effects of exercise programming vs traditional outpatient therapy in the rehabilitation of severely burned children // J. Burn Care Rehabil. – 2001. – Vol. 22, N. 3. – P. 214–220.; Murphy K.D., Lee J.O., Herndon D.N. Current pharmacotherapy for the treatment of severe burns // Expert Opin. Pharmacother. – 2003. – Vol. 4, N. 3. – P. 369–384.; Herndon D.N., Rodriguez N.A., Diaz E.C., et al. Long-term propranolol use in severely burned pediatric patients: a randomized controlled study // Ann. Surg. – 2012. – Vol. 256, N. 3. – P. 402–411.; Herndon D.N., Hart D.W., Wolf S.E., et al. Reversal of catabolism by beta-blockade after severe burns // N. Engl. J. Med. – 2001. – Vol. 345, N. 17. – P. 1223–1229.; Ali A., Herndon D.N., Mamachen A., et al. Propranolol attenuates hemorrhage and accelerates wound healing in severely burned adults // Crit. Care. – 2015. – N. 19. – P. 217.; Hart D.W., Wolf S.E., Ramzy P.I., et al. Anabolic effects of oxandrolone after severe burn // Ann. Surg. – 2001. – Vol. 233, N. 4. – P. 556–564.; Suman O.E., Thomas S.J., Wilkins J.P., et al. Effect of exogenous growth hormone and exercise on lean mass and muscle function in children with burns // J. Appl. Physiol. – 2003. – Vol. 94, N. 6. – P. 2273–2281.; Branski L.K., Herndon D.N., Barrow R.E., et al. Randomized controlled trial to determine the efficacy of long-term growth hormone treatment in severely burned children // Ann. Surg. – 2009. – Vol. 250, N. 4. – P. 514–523.; Takala J., Ruokonen E., Webster N.R., et al. Increased mortality associated with growth hormone treatment in critically ill adults // N. Engl. J. Med. – 1999. – Vol. 341, N. 11. – P. 785–792.; Moller S., Jensen M., Svensson P., Skakkebaek N.E. Insulin-like growth factor 1 (IGF-1) in burn patients // Burns. – 1991. – Vol. 17, N. 4. – P. 279–281.; Langouche L., Van den Berghe G. Glucose metabolism and insulin therapy // Crit. Care Clin. – 2006. – Vol. 22, N. 1. – P. 119–129.; Gauglitz G.G., Herndon D.N., Kulp G.A., et al. Abnormal insulin sensitivity persists up to three years in pediatric patients post-burn // J. Clin. Endocrinol. Metab. – 2009. – Vol. 94, N. 5. – P. 1656–1664.; Gornik I., Vujaklija-Brajkovic A., Renar I.P., et al. A prospective observational study of the relationship of critical illness associated hyperglycaemia in medical ICU patients and subsequent development of type 2 diabetes // Crit. Care. – 2010. – Vol. 14, N. 4. – R130.; Pidcoke H.F., Wade C.E., Wolf S.E. Insulin and the burned patient // Crit. Care Med. – 2007. – Vol. 35, N. 9. – Suppl. – S524–S530.; Jeschke M.G., Klein D., Herndon D.N. Insulin treatment improves the systemic inflammatory reaction to severe trauma // Ann. Surg. – 2004. – Vol. 239, N. 4. – P. 553–560.; Ferrando A.A., Chinkes D.L., Wolf S.E., et al. A submaximal dose of insulin promotes net skeletal muscle protein synthesis in patients with severe burns // Ann. Surg. – 1999. – Vol. 229. – P. 11–18.; Dellinger R.P., Levy M.M., Rhodes A., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012 // Crit. Care Med. – 2013. – Vol. 41., N. 2. – P. 580–637.; Gore D.C., Wolf S.E., Herndon D.N., et al. Metformin blunts stressinduced hyperglycemia after thermal injury // J. Trauma. – 2003. Vol. 54, N. 3. – P. 555–561.; Gore D.C., Herndon D.N., Wolfe R.R. Comparison of peripheral metabolic effects of insulin and metformin following severe burn injury // J. Trauma. – 2005. – Vol. 59, N. 2. – P. 316–322.; Luft D., Schmulling R.M., Eggstein M. Lactic acidosis in biguanide treated diabetics: a review of 330 cases // Diabetologia. – 1978. – Vol. 14, N. 2. – P. 75–87.; Bailey C.J., Turner R.C. Metformin // N. Engl. J. Med. – 1996. – Vol. 334, N. 9. – P. 574–579.; Williams F.N., Branski L.K., Jeschke M.G., et al. What, How, and How Much Should Patients with Burns be Fed? // Surg. Clin. North Am. – 2011. – Vol. 91, N. 3. – P. 609–629.; СмирновС.В., Лященко Ю.Н., Рык А.А., Хватов В.Б. Современные подходы к питательной поддержке в интенсивной терапии пациентов с термической травмой в стационаре скорой помощи // Скорая медицинская помощь. – 2010. – № 1. – С. 25–38.; Rousseau A.F., Losser M.R., Ichai C., Berger M.M. ESPEN endorsed recommendations: nutritional therapy in major burns // Clin. Nutr. – 2013. – Vol. 32, N. 4. – P. 497–502.; Deitch E.A. Intestinal permeability is increased in burn patients shortly after injury // Surgery. – 1990. – Vol. 107, N. 4. – P. 411–416.; Mochizuki H., Trocki O., Dominioni L., et al. Mechanism of prevention of postburn hypermetabolism an catabolism by early enteral feeding // Ann. Surg. – 1984. – Vol. 200, N. 3. – P. 297–310.; Chiarelli A., Enzi G., Casadei A., et al. Very early nutrition supplementation in burned patients // Am. J. Clin. Nutr. – 1990. – Vol. 51, N. 6. – P. 1035–1039.; McDonald W.S., Sharp C.W. Jr. Deitch E.A. Immediate enteral feeding in burn patients is safe and effective // Ann. Surg. – 1991. – Vol. 213, N. 2. – P. 177–183.; Venter M., Rode H., Sive A., Visser M. Enteral resuscitation and early enteral feeding in children with major burns-effect on McFarlane response to stress // Burns. – 2007. – Vol. 33, N. 4. – P. 464–471.; Barton R., Craft W., Mone M.C., Saffle J. Chemical paralysis reduces energy expenditure in mechanically ventilated trauma patients // J. Burn Care Rehabil. – 1997. – Vol. 18, N. 5. – P. 461–468.; Saffle J., Medina E., Raymond J., et al. Use of indirect calorimetry in the nutritional management of burn patients // J. Trauma. – 1985. – Vol. 25, N. 1. – P. 32–39.; Swinamer D., Phang P., Jones R., et al. Twenty-four hour energy expenditure in critically ill patient // Crit. Care Med. – 1987. – Vol. 15, N. 7. – P. 637–641.; Shaw-Delanty S., Elwyn D., Askanazi J., et al. Resting energy expenditure in injured, septic, and malnourished adult patients on intravenous diets // Clin. Nutr. – 1990. – Vol. 9, N. 6. – P. 305–312.; Hester D., Lawson K. Suggested guidelines for use by dietitians in the interpretation of indirect calorimetry data // J. Amer. Diet. Assoc. – 1989. – Vol. 89, N. 1. – P. 100–101.; Rimdeika R., Gudaviciene D., Adamonis K., et al. The effectiveness of caloric value of enteral nutrition in patients with major burns // Burns. – 2006. – Vol. 32, N. 1. – P. 83–86.; Berger M.M., Revelly J.P., Wasserfallen J.B., et al. Impact of a computerized information system on quality of nutritional support in the ICU // Nutrition. – 2006. – Vol. 22, N. 3. – P. 221–229.; Masters B., Aarabi S., Sidhwa F., Wood F. High-carbohydrate, high-protein, low-fat versus low-carbohydrate, high-protein, high-fat enteral feeds for burns // Cochrane Database Syst Rev. – 2012. – Vol. 1. – CD006122.; Gibson B.R., Galiatsatos P., Rabiee A., et al. Intensive insulin therapy confers a similar survival benefit in the burn intensive care unit to the surgical intensive care unit // Surgery. – 2009. – Vol. 146, N. 5. – P. 922–930.; Pham T.N., Warren A.J., Phan H.H., et al. Impact of tight glycemic control in severely burned children // J. Trauma. – 2005. – Vol. 59, N. 5. – P. 1148–1154.; Pidcoke H.F., Wanek S.M., Rohleder L.S., et al. Glucose variability is associated with high mortality after severe burn // J. Trauma. – 2009. – Vol. 67, N. 5. – P. 990–995.; Jeschke M.G., Kulp G.A., Kraft R., et al. Intensive insulin therapy in severely burned pediatric patients: a prospective randomized trial // Am. J. Respir. Crit. Care Med. – 2010. –– Vol. 182, N. 3. – P. 351–359.; van Zanten A.R., Dhaliwal R., Garrel D., et al. Enteral glutamine supplementation in critically ill patients: a systematic review and metaanalysis // Crit. Care. – 2015. – Vol. 19. – P. 294.; Coudray-Lucas C., LeBever H., Cynober L., et al. Ornithine aketoglutarate improves wound healing in severe burn patients: a prospective randomized double-blind trial versus isonitrogenous controls // Crit. Care Med. – 2000. – Vol. 28, N. 6. – P. 1772–1776.; Yan H., Peng X., Huang Y., et al. Effects of early enteral arginine supplementation on resuscitation of severe burn patients // Burns. – 2007. – Vol. 33, N. 2. – P. 179–184.; Gamliel Z., DeBiasse M., Demling R. Essential microminerals and their response to burn injury // J. Burn Care Rehabil. – 1996. – Vol. 17, N. 3. – P. 264–272.; Gottschlich M., Warden G. Vitamin supplementation in the patient with burns // J. Burn Care Rehabil. – 1990. – Vol. 11, N. 3. – P. 275–279.; Mayes T., Gottschlich M., Warden G. Clinical nutrition protocols for continuous quality improvement in the outcomes of patients with burns // J. Burn Care Rehabil. – 1997. –Vol. 18, N. 4. – P. 365–368.; Barbosa E., Faintuch J., Machado Moreira E.A., et al. Supplementation of vitamin E, vitamin C, and zinc attenuates oxidative stress in burned children: a randomized, double-blind, placebo-controlled pilot study // J. Burn Care Res. – 2009. – Vol. 30, N. 5. – P. 859–866.; Tanaka H., Matsuda T., Miyagantani Y., et al. Reduction of resuscitation fluid volumes in severely burned patients using ascorbic acid administration // Arch. Surg. – 2000. –Vol. 135, N. 3. – P. 326–331.; Falder S., Silla R., Phillips M., et al. Thiamine supplementation increases serum thiamine and reduces pyruvate and lactate levels in burn patients // Burns. – 2010. – Vol. 36, N. 2. – P. 261–269.; Klein G.L., Herndon D.N., Chen T.C., et al. Standard multivitamin supplementation does not improve vitamin D insufficiency after burns // J. Bone Miner. Metab. – 2009. – Vol. 27, N. 4. – P. 502–506.; Berger M.M., Baines M., Raffoul W., et al. Trace element supplements after major burns modulate antioxidant status andclinical course by way of increased tissue trace element concentration // Am. J. Clin. Nutr. – 2007. – Vol. 85, N. 5. – P. 1293–300.; Magnotti L., Deitch E. Burns, bacterial translocation, gut barrier function, and failure // J. Burn Care Rehabil. – 2005. – Vol. 26, N. 5. – P. 383–391.; Fong Y., Marano M., Barber E., et al. Total parenteral nutrition and bowel rest modify the metabolic response to endotoxin in humans // Ann. Surg. – 1989. – Vol. 210, N. 4. – P. 449–454.; Barret J.P., Jeschke M.G., Herndon D.N. Fatty infiltration of the liver in severely burned pediatric patients: autopsy findings and clinical implications // J. Trauma. – 2001. – Vol. 51, N. 4. – P. 736–739.; Andel H., Rab M., Andel D., et al. Impact of duodenal feeding on the oxygen balance of the splanchnic region during different phases of severe burn injury // Burns. – 2002. – Vol. 28, N. 1. – P. 60–64.; Saito H., Trocki O., Alexander J., et al. The effect of route of nutrient administration on the nutritional state, catabolic hormone secretion and gut mucosal integrity after burn injury // JPEN. – 1987. – Vol. 11, N. 1. – P. 1–7.; Stroud M., Duncan H., Nightingale J., et al. Guidelines for enteral feeding in adult hospital patients // Gut. – 2003. – Vol. 52. – Suppl 7. – vii1– vii12.; Kowal-Vern A., McGill V., Gamelli R. Ischemic necrotic bowel disease in thermal injury // Arch Surg. – 1997. –– Vol. 132, N. 4. – P. 440–443.; Markell K.W., Renz E.M., White C.E., et al. Abdominal complications after severe burns // J. Am. Coll. Surg. – 2009. –Vol. 208, N. 5. – P. 940–947.; Eisenberg P. Causes of diarrhea in tube-fed patients: a comprehensive approach to diagnosis and management // Nutr. Clin. Pract. – 1993. – Vol. 8, N. 3. – P. 119–123.; Kealey G., Aguillar J., Lewis R., et al. Cadaver skin allografts and transmission of human cytomegalovirus to burn patients // J. Am. Coll. Surg. – 1996. – Vol. 182, N. 3. – P. 201–205.; Grube B.J., Heimbach D.M., Marvin J.A. Clostridium difficile diarrhea in critically ill burned patients // Arch. Surg. – 1987. – Vol. 122, N. 6. – P. 655–661.; Gottschlich M., Warden G., Michel M., et al. Diarrhea in tube-fed burn patients: incidence, etiology, nutritional impact, and prevention // JPEN. – 1988. – Vol. 12, N. 4. – P. 338–345.; Whelan K., Schneider S.M. Mechanisms, prevention, and management of diarrhea in enteral nutrition // Curr Opin. Gastroenterol. – 2011. – Vol. 27, N. 2. – P. 152–159.; Scaife C.L., Saffle J.R., Morris S.E. Intestinal obstruction secondary to enteral feedings in burn trauma patients // J. Trauma. – 1999. – Vol. 47, N. 5. – P. 859–863.; Gump F., Kinney J. Energy balance and weight loss in burned patients // Arch. Surg. – 1971. – Vol. 103, N. 4. –P. 442–448.; Zdolsek H.J., Lindahl O.A., Angquist K.A., Sjöberg F. Non-invasive assessment of intercompartmental fluid shifts in burn victims // Burns. – 1998. – Vol. 24, N. 3. – P. 233–240.; Streat S., Beddoe A., Hill G. Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients // J. Trauma. – 1987. – Vol. 27, N. 3. – P. 262–266.; Hart D.W., Wolf S.E., Herndon D.N., et al. Energy expenditure and caloric balance after burn: Increased feeding leads to fat rather than lean mass accretion // Ann. Surg. – 2002. – Vol. 235, N. 1. – P. 152–161.; Graves C., Saffle J., Morris S. Comparison of urine urea nitrogen collection times in critically ill patients // Nutr. Clin. Pract. – 2005. – Vol. 20. – N. 2. – P. 271–275.; Konstantinides F., Radmer W., Becker W., et al. Inaccuracy of nitrogen balance determinations in thermal injury with calculated total urinary nitrogen // J. Burn Care Rehabil. – 1992. – Vol. 13, N. 2. – Pt. 1. – P. 254–260.; LeBlanc A., Gogia P., Schneider V., et al. Calf muscle area and strength changes after five weeks of horizontal bed rest // Am. J. Sports Med. – 1988. – Vol. 16, N. 6. – P. 624–629.; Greenhalgh D.G., Housinger T.A., Kagan R.J., et al. Maintenance of serum albumin levels in pediatric burn patients: a prospective, randomized trial // J. Trauma. – 1995. – Vol. 39, N. 1. – P. 67–73.; Sheridan R.L., Prelack K., Cunningham J.J. Physiologic hypoalbuminemia is well tolerated by severely burned children // J. Trauma. – 1997. – Vol. 43, N. 3. – P. 448–452.; Rettmer R., Williamson J., Labbe R., et al. Laboratory monitoring of nutrition status in burn patients // Clin. Chem. – 1992. – Vol. 38, N. 3. – P. 334–337.; Cynober L., Prugnaud O., Lioret H., et al. Serum transtyretin levels in patients with burn injury // Surgery. – 1991. – Vol. 109, N. 5. – P. 640–644.; Manelli J., Abdetii C., Botti G., et al. A reference standard for plasma proteins is required for nutritional assessment of adult burn patients // Burns. – 1998. – Vol. 24, N. 4. – P. 337–345.; Saffrey J.R., Graves C., Cochran A. Nutritional support of the burned patient // Total burn care / ed. D.N. Herndon. – 4th ed. – New York: Saunders Elsevier, 2012. – P. 348–349.; Kyle U.G., Nicod L., Raguso C., et al. Fat-free mass change to weight change ratio during refeeding following lung transplantation // Acta Diabetol. – 2003. – Vol. 40, Suppl. 1. – S165–S167.; Bachrach L.K. Dual energy X-ray absorptiometry (DEXA) measurements of bone density and body composition: promise and pitfalls // J. Pediatr. Endocrinol. Metab. – 2000. – Vol. 13, Suppl. 2. – S983–S988.; https://www.jnmp.ru/jour/article/view/296Test; undefined